Cochrane Abstracts
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Calcineurin Inhibitor Withdrawal or Tapering for Kidney Transplant Recipients." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432196/all/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients.
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432196/all/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients. Accessed January 12, 2025.
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432196/all/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients
Calcineurin Inhibitor Withdrawal or Tapering for Kidney Transplant Recipients [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2025 January 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432196/all/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
ID - 432196
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432196/all/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
